Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 8264830, 13 pages
http://dx.doi.org/10.1155/2016/8264830
Research Article

Inhibition of MEK1 Signaling Pathway in the Liver Ameliorates Insulin Resistance

1Research Division, Chugai Pharmaceutical Co., Ltd., 1-135 Komakado, Gotemba, Shizuoka 412-8513, Japan
2Department of Endocrinology, Diabetes and Geriatric Medicine, Akita University School of Medicine, 1-1-1 Hondo, Akita, Akita 010-8543, Japan
3Chugai Research Institute for Medical Science, 1-135 Komakado, Gotemba, Shizuoka 412-8513, Japan
4Project Planning & Coordination Department, Chugai Pharmaceutical Co., Ltd., 2-1-1 Nihonbashi, Muromachi, Chuo-ku, Tokyo 103-8324, Japan

Received 16 June 2015; Revised 26 September 2015; Accepted 29 September 2015

Academic Editor: Raffaella Mastrocola

Copyright © 2016 Atsunori Ueyama et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Atsunori Ueyama, Nobuhiro Ban, Masanori Fukazawa, et al., “Inhibition of MEK1 Signaling Pathway in the Liver Ameliorates Insulin Resistance,” Journal of Diabetes Research, vol. 2016, Article ID 8264830, 13 pages, 2016. https://doi.org/10.1155/2016/8264830.